Q1 2026 Management View Kim Kelderman, CEO, President & Director, reported that organic revenue declined 1% in Q1, ...

By combining stem cell expertise with SGAustria's encapsulation platform, the companies aim to produce safe solutions.

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...

Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers.

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...

For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of the medicinal product.

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable. This guide is designed to provide newly diagnosed patients with the necessary information ...

CURE had the privilege of attending the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, where medical experts gathered to discuss advances in research, treatment ...